315 related articles for article (PubMed ID: 34820870)
1. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.
Steiner HE; Gee K; Giles J; Knight H; Hurwitz BL; Karnes JH
Pharmacotherapy; 2022 Feb; 42(2):165-176. PubMed ID: 34820870
[TBL] [Abstract][Full Text] [Related]
2. A review of metabolic potential of human gut microbiome in human nutrition.
Yadav M; Verma MK; Chauhan NS
Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiome and Response to Cardiovascular Drugs.
Tuteja S; Ferguson JF
Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
[TBL] [Abstract][Full Text] [Related]
4. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
[TBL] [Abstract][Full Text] [Related]
5. Host-microbiome metabolism of a plant toxin in bees.
Motta EVS; Gage A; Smith TE; Blake KJ; Kwong WK; Riddington IM; Moran N
Elife; 2022 Dec; 11():. PubMed ID: 36472498
[TBL] [Abstract][Full Text] [Related]
6. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism.
Dikeocha IJ; Al-Kabsi AM; Miftahussurur M; Alshawsh MA
FASEB J; 2022 Jun; 36(6):e22350. PubMed ID: 35579628
[TBL] [Abstract][Full Text] [Related]
7. Bringing pharmacomicrobiomics to the clinic through well-designed studies.
Steiner HE; Patterson HK; Giles JB; Karnes JH
Clin Transl Sci; 2022 Oct; 15(10):2303-2315. PubMed ID: 35899413
[TBL] [Abstract][Full Text] [Related]
8. Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment.
Rana D; Salave S; Perla A; Nadkarni A; Kolhe S; Jindal AB; Mandoli A; Dwivedi P; Benival D
Curr Drug Targets; 2022; 23(9):869-888. PubMed ID: 35264088
[TBL] [Abstract][Full Text] [Related]
9. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
10. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma A; Buschmann MM; Gilbert JA
Clin Pharmacol Ther; 2019 Aug; 106(2):317-328. PubMed ID: 30937887
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
12. Gut microbes in cardiovascular diseases and their potential therapeutic applications.
Jin L; Shi X; Yang J; Zhao Y; Xue L; Xu L; Cai J
Protein Cell; 2021 May; 12(5):346-359. PubMed ID: 32989686
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects.
Leigh SJ; Lynch CMK; Bird BRH; Griffin BT; Cryan JF; Clarke G
Expert Opin Drug Metab Toxicol; 2022 Jan; 18(1):5-26. PubMed ID: 35176217
[TBL] [Abstract][Full Text] [Related]
14. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
15. Human Gut Microbiota and Drug Metabolism.
Pant A; Maiti TK; Mahajan D; Das B
Microb Ecol; 2023 Jul; 86(1):97-111. PubMed ID: 35869999
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome: The Interplay of an "Invisible Organ" with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders.
Lim DW; Wang JH
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293657
[TBL] [Abstract][Full Text] [Related]
17. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
18. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability.
Tsunoda SM; Gonzales C; Jarmusch AK; Momper JD; Ma JD
Clin Pharmacokinet; 2021 Aug; 60(8):971-984. PubMed ID: 33959897
[TBL] [Abstract][Full Text] [Related]
20. Genetic Engineering of Resident Bacteria in the Gut Microbiome.
Arnold J; Glazier J; Mimee M
J Bacteriol; 2023 Jul; 205(7):e0012723. PubMed ID: 37382533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
